Table 1. Effects of histone deacetylase inhibitors in inflammatory and autoimmune diseases.
Disease model | Species | Inhibitor | Effects |
---|---|---|---|
Endotoxin | Human, mouse |
SAHA | Reduced cytokine production (TNF- α, IL-1β, IL-6, IFN-γ) and lethality in vivo in mice77-79; decreased cytokine production in vitro using human PBMC78 |
ConA hepatitis | Mouse | SAHA | Decreased liver injury78 |
Airway hypersensitivity | Mouse | TsA | Decreased allergen-induced airway inflammation in a model of asthma, with decreased airway hyperresponsiveness, mucus production, leukocyte infiltration and cytokine production93 |
Experimental autoimmune encephalomyelitis |
Mouse | TsA | Decreased demyelination, leukocyte infiltration and TH1 cytokine and chemokine production in relapsing phase of experimental autoimmune encephalomyelitis94 |
Stroke | Mouse | SAHA, TsA | Decreased infarct size post-middle cerebral artery occlusion103 |
Neurodegenerative diseases |
Mouse | Butyrate106,107, SAHA105 |
Decreased disease progression in models of Huntington’s chorea105, spinal and muscular dystrophy106, amyotrophic lateral sclerosis107 |
Colitis | Mouse | SAHA, TsA | Decreased weight loss, histological injury, leukocyte infiltration and cytokine production in dextran sodium sulphate- and,4,6- trinitrobenzene sulphonic acid-induced colitis and adoptive transfer models7,26,96 |
Glomerulonephritis | Mouse | SAHA, TsA | Decreased proteinuria in MRL/lpr model of systemic lupus erythematosus, and decreased leukocyte infiltration and production of inflammatory mediators95 |
Arthritis | Mouse, rat | FK22897, SAHA and MS27598, VPA19, |
Decreased joint swelling and bone and cartilage destruction in antibody-97 and collagen-induced28,98 models of arthritis, in conjunction with decreased overall leukocyte infiltration and TH1 cytokine and chemokine production, but increased Foxp3+ Treg accumulation19 |
Graft-versus-host disease |
Mouse | SAHA | Decreased graft-versus-host disease99 and decreased CD3 monoclonal antibody-induced cytokine storm during bone marrow conditioning100 |
Transplant rejection | Mouse | SAHA, TsA, | Permanent engraftment of cardiac and islet allografts and Foxp3+ Treg-dependent tolerance induction7 |
Haemorrhage and resuscitation |
Human, mouse, rat, pig |
Butyrate, SAHA, TsA, VPA |
Optimal protective effects with SAHA compared with TsA or VPA in a rat model109; SAHA-induced suppression of TNF-α production in rats but variable effects in humans110; VPA-associated increased expression of multiple protective genes in additional studies using pig111 and rat112 models, including BCL2 and HSP70 (REF. 111) |
CD3, cluster of differentiation 3; HSP70, heat shock protein 70; IFN, interferon; IL, interleukin; PBMC, peripheral blood mononuclear cell; SAHA, suberoylanilide hydroxamic acid; TNF, tumour necrosis factor; Treg, regulatory T cell; TH1, type 1 helper T cell; TsA, trichostatin A (TsA); VPA, valproic acid.